Fig. 4From: Pan-cancer analysis identified IGF2BP2 as a potential prognostic biomarker for multiple tumor typesAssociation between IGF2BP2 expression and progression-free interval (PFI). A Forest plot of PFI association with IGF2BP2 expression in 33 types of tumor. B–G Kaplan–Meier analysis of the association between IGF2BP2 expression and PFIBack to article page